Checkpoint kinase Chk2 controls renal Cyp27b1 expression, calcitriol formation, and calcium-phosphate metabolism

Area of Science:

• Endocrinology
• Molecular Biology
• Nephrology

Background:

• Checkpoint kinase 2 (Chk2) is a key effector of ATM signaling, crucial for cell cycle regulation.
• ATM signaling upregulates interferon-regulating factor-1 (IRF-1), a transcription factor present in the kidney.
• Calcitriol (1,25 (OH)2D3), a vital regulator of mineral metabolism, is synthesized in the kidney by 25-hydroxyvitamin D 1α-hydroxylase, whose expression is enhanced by IRF-1.

Purpose of the Study:

• To investigate the role of Chk2 in calcitriol formation and mineral metabolism.
• To determine if Chk2 deficiency affects renal 25-hydroxyvitamin D 1α-hydroxylase expression and consequently mineral homeostasis.

Main Methods:

• Comparison of Chk2-deficient (chk2 (-/-)) and wild-type (chk2 (+/+)) mice.
• Analysis of renal gene expression (25-hydroxyvitamin D 1α-hydroxylase, Chk2, IRF-1, Klotho) via RT-PCR and Western blotting.
• Measurement of serum/plasma levels (1,25 (OH)2D3, PTH, FGF23) and mineral concentrations (calcium, phosphate) in serum, feces, and urine.

Main Results:

• Chk2 deficiency led to significantly lower renal expression of IRF-1 and 25-hydroxyvitamin D 1α-hydroxylase.
• Serum 1,25 (OH)2D3 and FGF23 levels were reduced in chk2 (-/-) mice.
• Despite hypophosphatemia and normocalcemia, chk2 (-/-) mice exhibited higher renal calcium and phosphate excretion.

Conclusions:

• Chk2 plays a regulatory role in renal 25-hydroxyvitamin D 1α-hydroxylase expression.
• Chk2 influences calcium and phosphate metabolism, likely through its effect on calcitriol synthesis.
• The findings highlight a novel link between Chk2 signaling and mineral homeostasis.